Hemodynamic effects of intravenous administration of amiodarone in congestive heart failure from chronic chagas' disease
Authors:
- Giovanni BellottiGBGiovanni Bellotti
- Lélio A. SilvaLSLélio A. Silva
- Antonio Esteves FilhoAFAntonio Esteves Filho
- Miguel RatiMRMiguel Rati
- Álvaro V. de MoraesÁMÁlvaro V. de Moraes
- Joséantonio F. RamiresJRJoséantonio F. Ramires
- Protásio da LuzPLProtásio da Luz
- Fúlvio PileggiFPFúlvio Pileggi
- 1 November 1983
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 52 (8) , 1046-1049
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Intravenous amiodarone in atrial fibrillation complicating myocardial infarctionBMJ, 1982
- Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone.Circulation, 1981
- Clinical pharmacology and therapeutic applications of the antiarrhythmic agent, amiodaroneAmerican Heart Journal, 1981
- Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmiasAmerican Heart Journal, 1981
- Intravenous amiodarone in ventricular fibrillation.BMJ, 1981
- Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal tachycardias.Heart, 1980
- Effects of amiodarone on cardiac and coronary hemodynamics and on myocardial metabolism in patients with coronary artery disease.Circulation, 1979
- Effects of amiodarone studied by programmedelectrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardiaJournal of Electrocardiology, 1978
- Clinical efficacy of amiodarone as an antiarrhythmic agentThe American Journal of Cardiology, 1976
- Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochlorideThe American Journal of Cardiology, 1974